GTx (Pharmaceuticals) is Biotechnology in United States that focus on serious medical conditions business. Founded in 1997. They cover business area such as GTx Inc, discovery, development, commercialization, small molecule, cancer, treatment, stress urinary incontinence, Duchenne muscular dystrophy, its lead product candidate, Enobosarm, selective androgen receptor modulator.
1997
( 27 years old in 2024 )
Serious Medical Conditions
-
175 Toyota Plaza
7th Floor
Memphis, TN 38103
United States
Private
GTx Incdiscoverydevelopmentcommercializationsmall moleculecancertreatmentstress urinary incontinenceDuchenne muscular dystrophyits lead product candidateEnobosarmselective androgen receptor modulator
* We use standard office opening hours in near GTx (Pharmaceuticals)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
GTx (Pharmaceuticals) is Biotechnology business from United States that founded in 1997 (27 years old in 2024), GTx (Pharmaceuticals) business is focusing on Serious Medical Conditions.
GTx (Pharmaceuticals) headquarter office and corporate office address is located in 175 Toyota Plaza 7th Floor Memphis, TN 38103 United States.
GTx (Pharmaceuticals) was founded in United States.
In 2024, GTx (Pharmaceuticals) is currently focus on serious medical conditions sector.
Above is snippet of Google Trends for "serious medical conditions" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with GTx (Pharmaceuticals), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
